Ark Invest pours $52 million into SpaceX as portfolio rebalancing continues

The latest trading disclosures reveal that Space Exploration Technologies Corp. now claims the firm’s largest allocation by value across multiple exchange-traded funds, including ARKK, ARKQ, ARKW, and ARKX. This purchase cycle builds on earlier efforts to accumulate SpaceX stock following its post-IPO price decline. Wood recently asserted that the company maintains a decade-long lead over industry competitors, with internal models projecting an enterprise value between $2.5 trillion and $3.1 trillion by 2030.

Beyond aerospace, the firm expanded its footprint in AI and digital finance, picking up shares of Meta Platforms, Coinbase Global, Circle Internet Group, and X-Energy. A diverse array of healthcare and defense-related firms, such as Kratos Defense & Security Solutions and Ionis Pharmaceuticals, also saw increased investment. Conversely, the rebalancing act forced exits or reductions in Advanced Micro Devices, Roku, and Deere. A broad retreat from the genomics sector was also evident, with sell-offs hitting Natera, Illumina, and BioNTech. These adjustments arrive as Ark manages its internal weightings, ensuring no single holding exceeds its 10% portfolio threshold ahead of the second-quarter earnings season.